The DOI matches its Crossref record; 116 of the 116 references it cites were found in a registry or an index.
Crystal Structure of the Human Cannabinoid Receptor CB1
Open accessAbstract
SUMMARY Cannabinoid receptor 1 (CB1) is the principal target of Δ9-tetrahydrocannabinol (THC), a psychoactive chemical from Cannabis sativa with a wide range of therapeutic applications and a long history of recreational use. CB1 is activated by endocannabinoids, and is a promising therapeutic target for pain management, inflammation, obesity and substance abuse disorders. Here, we present the 2.8 Å crystal structure of human CB1 in complex with AM6538, a stabilizing antagonist, synthesized and characterized for this structural study. The structure of the CB1-AM6538 complex reveals key features of the receptor and critical interactions for antagonist binding. In combination with functional studies and molecular modeling, the structure provides insight into the binding mode of naturally occurring CB1 ligands, such as THC, and synthetic cannabinoids. This enhances our understanding of the molecular basis for the physiological functions of CB1 and provides new opportunities for the design of next-generation CB1-targeting pharmaceuticals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Crystal structures of agonist-bound human cannabinoid receptor CB1
Hua, T., Vemuri, K., Nikas, S. P., Laprairie, R. B., Wu, Y., Qu, L., Pu, M., Korde, A., Jiang, S., Ho, J.-H., et al. (2017) · Nature · doi:10.1038/nature23272 · Cited by 479
Self-citationRetractedMAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047337 · Cited by 16,463
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., et al. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21367 · Cited by 7,509
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Deciphering key features in protein structures with the new ENDscript server
Robert, X., & Gouet, P. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku316 · Cited by 7,053
Friesner, R. A., Murphy, R. B., Repasky, M. P., Frye, L. L., Greenwood, J. R., Halgren, T. A., Sanschagrin, P. C., & Mainz, D. T. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051256o · Cited by 6,851
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633
Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030644s · Cited by 5,177
Molecular characterization of a peripheral receptor for cannabinoids
Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Best, R. B., Zhu, X., Shim, J., Lopes, P. E. M., Mittal, J., Feig, M., & MacKerell, A. D. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300400x · Cited by 4,532
Mackerell, A. D., Feig, M., & Brooks, C. L. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20065 · Cited by 3,319
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in Neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 2,999
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913
Integration, scaling, space-group assignment and post-refinement
Kabsch, W. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909047374 · Cited by 2,528
Determination and characterization of a cannabinoid receptor in rat brain
Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×
“This assumption was challenged with the discovery, cloning, and expression of the first cannabinoid-specific membrane receptor, then designated as the cannabinoid receptor (CB) (Devane et al., 1988; Matsuda et al., 1990).”
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
SwissParam: A fast force field generation tool for small organic molecules
Zoete, V., Cuendet, M. A., Grosdidier, A., & Michielin, O. (2011) · Journal of Computational Chemistry · doi:10.1002/jcc.21816 · Cited by 2,370
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis
Whiting, P. F., Wolff, R. F., Deshpande, S., Di Nisio, M., Duffy, S., Hernandez, A. V., Keurentjes, J. C., Lang, S., Misso, K., Ryder, S., et al. (2015) · JAMA · doi:10.1001/jama.2015.6358 · Cited by 2,169
Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects
Sherman, W., Day, T., Jacobson, M. P., Friesner, R. A., & Farid, R. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050540c · Cited by 2,031
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Identification and Functional Characterization of Brainstem Cannabinoid CB2Receptors
Van Sickle, M. D., Duncan, M., Kingsley, P. J., Mouihate, A., Urbani, P., Mackie, K., Stella, N., Makriyannis, A., Piomelli, D., Davison, J. S., et al. (2005) · Science · doi:10.1126/science.1115740 · Cited by 1,470
Self-citationGPCRdb: an information system for G protein-coupled receptors
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,072
Abagyan, R., & Totrov, M. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1052 · Cited by 975
Yu, W., He, X., Vanommeslaeghe, K., & MacKerell, A. D. (2012) · Journal of Computational Chemistry · doi:10.1002/jcc.23067 · Cited by 922
Activation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Felder, C. C., Joyce, K. E., Briley, E. M., Mansouri, J., Mackie, K., Blond, O., Lai, Y., Ma, A. L., & Mitchell, R. L. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10492-6 · Cited by 869
Structure and dynamics of the M3 muscarinic acetylcholine receptor
Kruse, A. C., Hu, J., Pan, A. C., Arlow, D. H., Rosenbaum, D. M., Rosemond, E., Green, H. F., Liu, T., Chae, P. S., Dror, R. O., et al. (2012) · Nature · doi:10.1038/nature10867 · Cited by 811
An Improved Empirical Potential Energy Function for Molecular Simulations of Phospholipids
Feller, S. E., & MacKerell, A. D. (2000) · The Journal of Physical Chemistry B · doi:10.1021/jp0007843 · Cited by 766
SR 144528, the First Potent and Selective Antagonist of the CB2 Cannabinoid Receptor
Rinaldi-Carmona, M., Barth, F., Millan, J., Derocq, J.-M., Casellas, P., Congy, C., Oustric, D., Sarran, M., Bouaboula, M., Calandra, B., et al. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37266-0 · Cited by 709
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Crystal Structure of a Lipid G Protein–Coupled Receptor
Hanson, M. A., Roth, C. B., Jo, E., Griffith, M. T., Scott, F. L., Reinhart, G., Desale, H., Clemons, B., Cahalan, S. M., Schuerer, S. C., et al. (2012) · Science · doi:10.1126/science.1215904 · Cited by 666
Self-citationBen-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., & Mechoulam, R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00392-6 · Cited by 629
CB2: a cannabinoid receptor with an identity crisis
Atwood, B. K., & Mackie, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00729.x · Cited by 619
Smart, O. S., Womack, T. O., Flensburg, C., Keller, P., Paciorek, W., Sharff, A., Vonrhein, C., & Bricogne, G. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911056058 · Cited by 612
Shimizu, T. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145616 · Cited by 576
Showalter, V. M., Compton, D. R., Martin, B. R., & Abood, M. E. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20744-3 · Cited by 571
Structure of the agonist-bound neurotensin receptor
White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., et al. (2012) · Nature · doi:10.1038/nature11558 · Cited by 509
Hermanns‐Clausen, M., Kneisel, S., Szabo, B., & Auwärter, V. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04078.x · Cited by 479
Fusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Self-citationTam, J., Vemuri, V. K., Liu, J., Bátkai, S., Mukhopadhyay, B., Godlewski, G., Osei-Hyiaman, D., Ohnuma, S., Ambudkar, S. V., Pickel, J., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42551 · Cited by 454
Self-citationMicroscale Fluorescent Thermal Stability Assay for Membrane Proteins
Alexandrov, A. I., Mileni, M., Chien, E. Y. T., Hanson, M. A., & Stevens, R. C. (2008) · Structure · doi:10.1016/j.str.2008.02.004 · Cited by 449
Self-citationStructure−Activity Relationships of Pyrazole Derivatives as Cannabinoid Receptor Antagonists
Lan, R., Liu, Q., Fan, P., Lin, S., Fernando, S. R., McCallion, D., Pertwee, R., & Makriyannis, A. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980363y · Cited by 447
Self-citationGuindon, J., & Hohmann, A. G. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707531 · Cited by 423
High-resolution crystal structure of the human CB1 cannabinoid receptor
Shao, Z., Yin, J., Chapman, K., Grzemska, M., Clark, L., Wang, J., & Rosenbaum, D. M. (2016) · Nature · doi:10.1038/nature20613 · Cited by 419
An archaeological and historical account of cannabis in China
Li, H.-L. (1973) · Economic Botany · doi:10.1007/bf02862859 · Cited by 386
Structure-activity relationships in cannabinoids.
Razdan, R. K. (1986) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06863-2 · Cited by 370
CB2receptors in the brain: role in central immune function
Cabral, G. A., Raborn, E. S., Griffin, L., Dennis, J., & Marciano‐Cabral, F. (2008) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707584 · Cited by 342
Crystal structures of the M1 and M4 muscarinic acetylcholine receptors
Thal, D. M., Sun, B., Feng, D., Nawaratne, V., Leach, K., Felder, C. C., Bures, M. G., Evans, D. A., Weis, W. I., Bachhawat, P., et al. (2016) · Nature · doi:10.1038/nature17188 · Cited by 335
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus
Stempel, A. V., Stumpf, A., Zhang, H.-Y., Özdoğan, T., Pannasch, U., Theis, A.-K., Otte, D.-M., Wojtalla, A., Rácz, I., Ponomarenko, A., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.034 · Cited by 292
Distinct Domains of the CB1 Cannabinoid Receptor Mediate Desensitization and Internalization
Jin, W., Brown, S., Roche, J. P., Hsieh, C., Celver, J. P., Kovoor, A., Chavkin, C., & Mackie, K. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-10-03773.1999 · Cited by 261
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 255
Influence of the N-1 alkyl chain length of cannabimimetic indoles upon CB1 and CB2 receptor binding
Aung, M. M., Griffin, G., Huffman, J. W., Wu, M.-J., Keel, C., Yang, B., Showalter, V. M., Abood, M. E., & Martin, B. R. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00152-0 · Cited by 254
Structure-Activity Relationships of Indole- and Pyrrole-Derived Cannabinoids
Wiley, J. L., Compton, D. R., Dai, D., Lainton, J. A. H., Phillips, M., Huffman, J. W., & Martin, B. R. (1998) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37496-8 · Cited by 240
Song, Z. H., & Bonner, T. I. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09082-0 · Cited by 206
Crystal Structure of Antagonist Bound Human Lysophosphatidic Acid Receptor 1
Chrencik, J. E., Roth, C. B., Terakado, M., Kurata, H., Omi, R., Kihara, Y., Warshaviak, D., Nakade, S., Asmar-Rovira, G., Mileni, M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.06.002 · Cited by 204
Self-citationThe endogenous cannabinoid system and its role in nociceptive behavior
Cravatt, B. F., & Lichtman, A. H. (2004) · Journal of Neurobiology · doi:10.1002/neu.20080 · Cited by 203
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease
Mazier, W., Saucisse, N., Gatta-Cherifi, B., & Cota, D. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.007 · Cited by 200
Janero, D. R., & Makriyannis, A. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902736568 · Cited by 186
Self-citationMcAllister, S. D., Rizvi, G., Anavi-Goffer, S., Hurst, D. P., Barnett-Norris, J., Lynch, D. L., Reggio, P. H., & Abood, M. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0302647 · Cited by 185
Pan, X., Ikeda, S. R., & Lewis, D. L. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.6.1064 · Cited by 185
Cannabinoids and multiple sclerosis
Pertwee, R. G. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00255-3 · Cited by 181
Kandasamy, S. K., & Larson, R. G. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.073395 · Cited by 177
Kuster, J. E., Stevenson, J. I., Ward, S. J., D'Ambra, T. E., & Haycock, D. A. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10152-3 · Cited by 164
Cannabinoid signaling and liver therapeutics
Mallat, A., Teixeira-Clerc, F., & Lotersztajn, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.032 · Cited by 161
Keynote review: Medicinal chemistry strategies to CB1 cannabinoid receptor antagonists
Lange, J. H. M., & Kruse, C. G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03427-6 · Cited by 160
Hurst, D. P., Lynch, D. L., Barnett-Norris, J., Hyatt, S. M., Seltzman, H. H., Zhong, M., Song, Z.-H., Nie, J., Lewis, D., & Reggio, P. H. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1274 · Cited by 160
Cherezov, V., Hanson, M. A., Griffith, M. T., Hilgart, M. C., Sanishvili, R., Venugopalan, N., Stepanov, S. A., Fischetti, R. F., Kühn, P., & Stevens, R. C. (2009) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0142.focus · Cited by 156
Self-citationFernández‐Ruíz, J., Romero, J., & Ramos, J. A. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_8 · Cited by 146
Song, Z. H., Slowey, C.-A., Hurst, D. P., & Reggio, P. H. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12547-3 · Cited by 125
Gatley, S. J., Lan, R., Volkow, N. D., Pappas, N. R., King, P. T., Wong, C., Gifford, A. N., Pyatt, B. E., Dewey, S. L., & Makriyannis, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010417.x · Cited by 124
Self-citationMembrane Assembly of the Cannabinoid Receptor 1: Impact of a Long N-Terminal Tail
Andersson, H. M., D’Antona, A. M., Kendall, D. A., von HEIJNE, G., & Chin, C. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.3.570 · Cited by 123
Biology and therapeutic potential of cannabinoid CB2receptor inverse agonists
Lunn, C. A., Reich, E., Fine, J. S., Lavey, B. J., Kozlowski, J. A., Hipkin, R. W., Lundell, D. J., & Bober, L. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707480 · Cited by 120
Bramblett, R. D., Panu, A. M., Ballesteros, J. A., & Reggio, P. H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00178-9 · Cited by 117
Cannabinoids and Multiple Sclerosis
Pertwee, R. G. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0005-2 · Cited by 112
Horti, A. G., Gao, Y., Ravert, H. T., Finley, P. A., Valentine, H., Wong, D. F., Endres, C. J., Savonenko, A. V., & Dannals, R. F. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.05.058 · Cited by 112
Fong, T. M., Guan, X.-M., Marsh, D. J., Shen, C.-P., Stribling, D. S., Rosko, K., Lao, J. Z., Yu, H., Feng, Y., Xiao, J. C., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.118737 · Cited by 105
The molecular basis of cannabinoid activity
Makriyannis, A., & Rapaka, R. S. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90147-j · Cited by 104
Self-citationPei, Y., Mercier, R. W., Anday, J. K., Thakur, G. A., Zvonok, A. M., Hurst, D. P., Reggio, P. H., Janero, D. R., & Makriyannis, A. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.10.011 · Cited by 102
Self-citationPicone, R. P., Khanolkar, A. D., Xu, W., Ayotte, L. A., Thakur, G. A., Hurst, D. P., Abood, M. E., Reggio, P. H., Fournier, D. J., & Makriyannis, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.014407 · Cited by 100
Self-citationEndocannabinoids and Mental Disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_9 · Cited by 80
Chin, C., Lucas-Lenard, J. M., Abadji, V., & Kendall, D. A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70010366.x · Cited by 76
Schindler, C. W., Redhi, G. H., Vemuri, K., Makriyannis, A., Le Foll, B., Bergman, J., Goldberg, S. R., & Justinova, Z. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.27 · Cited by 73
Self-citationIn vitro expression and analysis of the 826 human G protein-coupled receptors
Lv, X., Liu, J., Shi, Q., Tan, Q., Wu, D., Skinner, J. J., Walker, A. L., Zhao, L., Gu, X.-X., Chen, N., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0263-8 · Cited by 72
Self-citationGriffith, D. A., Hadcock, J. R., Black, S. C., Iredale, P. A., Carpino, P. A., DaSilva-Jardine, P. A., Day, R. F., DiBrino, J., Dow, R. L., Landis, M. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8012932 · Cited by 66
Potential Therapeutic Usefulness of Marijuana
Lemberger, L. (1980) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.20.040180.001055 · Cited by 65
Makriyannis, A. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500220s · Cited by 63
Self-citationFay, J. F., Dunham, T. D., & Farrens, D. (2005) · Biochemistry · doi:10.1021/bi0472651 · Cited by 61
Tetrahydrocannabinol Homologs with Doubly Branched Alkyl Groups in the 3-Position. XVIII1
ADAMS, R. L. P., MacKenzie, S., & Loewe, S. (1948) · Journal of the American Chemical Society · doi:10.1021/ja01182a068 · Cited by 61
Isolation of a Physiologically Active Tetrahydrocannabinol from Cannabis Sativa Resin
Wollner, H. J., Matchett, J. R., Levine, J., & Loewe, S. (1942) · Journal of the American Chemical Society · doi:10.1021/ja01253a008 · Cited by 61
D’Antona, A. M., Ahn, K. H., & Kendall, D. A. (2006) · Biochemistry · doi:10.1021/bi060067k · Cited by 59
Lucchesi, V., Hurst, D. P., Shore, D. M., Bertini, S., Ehrmann, B. M., Allarà, M., Lawrence, L., Ligresti, A., Minutolo, F., Saccomanni, G., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500807e · Cited by 57
Berding, G., Müller-Vahl, K., Schneider, U., Gielow, P., Fitschen, J., Stuhrmann, M., Harke, H., Buchert, R., Donnerstag, F., Hofmann, M., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.005 · Cited by 54
Black, M. D., Stevens, R. J., Rogacki, N., Featherstone, R. E., Senyah, Y., Giardino, O. Z., Borowsky, B., Stemmelin, J., Cohen, C., Pichat, P., et al. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2124-0 · Cited by 53
Self-citationYeates, R. A., Laufen, H., & Leitold, M. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14198-9 · Cited by 53
Han, S., Zhang, F., Qian, H., Chen, L., Pu, J.-B., Xie, X., & Chen, J. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00227 · Cited by 51
Fay, J. F., & Farrens, D. (2013) · Biochemistry · doi:10.1021/bi400842k · Cited by 45
Szymanski, D. W., Papanastasiou, M., Melchior, K., Zvonok, N., Mercier, R. W., Janero, D. R., Thakur, G. A., Cha, S., Wu, B., Karger, B. L., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr2005583 · Cited by 43
Self-citationEndocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis
Pryce, G., & Baker, D. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-20825-1_7 · Cited by 40
Mercier, R. W., Pei, Y., Pandarinathan, L., Janero, D. R., Zhang, J., & Makriyannis, A. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.08.010 · Cited by 35
Self-citation3′-Functionalized Adamantyl Cannabinoid Receptor Probes
Ogawa, G., Tius, M. A., Zhou, H., Nikas, S. P., Aneetha, H., Mallipeddi, S., & Makriyannis, A. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501960u · Cited by 32
Self-citationContino, M., Capparelli, E., Colabufo, N. A., & Bush, A. I. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00196 · Cited by 31
Janero, D. R., Yaddanapudi, S., Zvonok, N., Subramanian, K. V., Shukla, V. G., Stahl, E. L., Zhou, L., Hurst, D. P., Wager‐Miller, J., Bohn, L., et al. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00090 · Cited by 27
Self-citationJanero, D. R., Lindsley, L., Vemuri, K. V., & Makriyannis, A. (2011) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2011.608063 · Cited by 25
Self-citationPattison, F. L. M., & Brown, G. M. (1956) · Canadian Journal of Chemistry · doi:10.1139/v56-116 · Cited by 24
Ligand binding sensitivity of the extracellular loop two of the cannabinoid receptor 1
Bertalovitz, A. C., Ahn, K. H., & Kendall, D. A. (2010) · Drug Development Research · doi:10.1002/ddr.20388 · Cited by 19
Bohn, L., Zhou, L., & Ho, J. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2914-6_12 · Cited by 15
Self-citation
Cited by
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
Zou, S., & Kumar, U. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030833 · Cited by 1,343
Punjani, A., & Fleet, D. J. (2021) · Journal of Structural Biology · doi:10.1016/j.jsb.2021.107702 · Cited by 977
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560
Self-citationRETRACTED ARTICLE: Crystal structures of agonist-bound human cannabinoid receptor CB1
Hua, T., Vemuri, K., Nikas, S. P., Laprairie, R. B., Wu, Y., Qu, L., Pu, M., Korde, A., Jiang, S., Ho, J.-H., et al. (2017) · Nature · doi:10.1038/nature23272 · Cited by 479
Self-citationRetracted
Metadata
- Authors
- Hua, T., Vemuri, K., Pu, M., Qu, L., Han, G. W., Wu, Y., Zhao, S., Shui, W., Li, S., Korde, A., Laprairie, R. B., Stahl, E. L., Ho, J.-H., Zvonok, N., Zhou, H., Kufareva, I., Wu, B., Zhao, Q., Hanson, M. A., Bohn, L. M., Makriyannis, A., Stevens, R. C., & Liu, Z.-J.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 167
- Issue
- 3
- Pages
- 750-762.e14
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2533852048
- Cited by
- 673
- References
- 116
- FWCI
- 52.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.